Dipharma
Dipharma, officially known as Dipharma S.A., is a prominent player in the pharmaceutical industry, headquartered in Montana (MT). Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates, serving a global clientele. With a strong operational presence across Europe and North America, Dipharma is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of APIs tailored for various therapeutic areas, distinguished by their high purity and compliance with stringent regulatory standards. Dipharma's dedication to research and development has led to significant milestones, positioning it as a trusted partner in the pharmaceutical supply chain. Its reputation for excellence is further underscored by numerous industry accolades, reflecting its pivotal role in advancing healthcare solutions.
DitchCarbon Score
How does Dipharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dipharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dipharma's reported carbon emissions
Dipharma, headquartered in MT, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that Dipharma has not outlined any formal reduction targets or commitments to climate initiatives. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its commitments. As the industry increasingly prioritises sustainability and carbon reduction, it will be essential for Dipharma to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dipharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
